Development of a bioassay to detect T-cell-activating impurities for T-cell-dependent bispecific antibodies

T-cell-dependent bispecific antibodies (TDBs) are promising cancer immunotherapies that recruit a patient’s T cells to kill cancer cells. There are increasing numbers of TBDs in clinical trials, demonstrating their widely recognized therapeutic potential. Due to the fact that TDBs engage and activat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ho Young, Contreras, Edward, Register, Ames C., Wu, Qiang, Abadie, Kathleen, Garcia, Khristofer, Wong, Pin Yee, Jiang, Guoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405939/
https://www.ncbi.nlm.nih.gov/pubmed/30846832
http://dx.doi.org/10.1038/s41598-019-40689-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405939/
https://www.ncbi.nlm.nih.gov/pubmed/30846832
http://dx.doi.org/10.1038/s41598-019-40689-1

Ejemplares similares